ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 201 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,127,000 | -51.8% | 43,700 | 0.0% | 0.12% | -54.9% |
| Q4 2020 | $2,336,000 | +24.7% | 43,700 | -3.7% | 0.26% | +9.4% |
| Q3 2020 | $1,873,000 | -16.0% | 45,400 | -1.3% | 0.23% | -26.5% |
| Q2 2020 | $2,230,000 | +16.0% | 46,000 | +1.1% | 0.32% | -3.6% |
| Q1 2020 | $1,922,000 | -1.2% | 45,500 | 0.0% | 0.33% | +11.1% |
| Q4 2019 | $1,946,000 | +18.8% | 45,500 | 0.0% | 0.30% | +8.4% |
| Q3 2019 | $1,638,000 | +47.7% | 45,500 | +9.6% | 0.27% | +40.7% |
| Q2 2019 | $1,109,000 | -0.4% | 41,500 | 0.0% | 0.19% | -6.3% |
| Q1 2019 | $1,114,000 | +66.0% | 41,500 | 0.0% | 0.21% | +52.2% |
| Q4 2018 | $671,000 | -22.2% | 41,500 | 0.0% | 0.14% | -9.9% |
| Q3 2018 | $862,000 | +36.0% | 41,500 | 0.0% | 0.15% | +30.2% |
| Q2 2018 | $634,000 | -32.0% | 41,500 | 0.0% | 0.12% | -29.3% |
| Q1 2018 | $933,000 | -25.4% | 41,500 | 0.0% | 0.16% | -13.2% |
| Q4 2017 | $1,250,000 | – | 41,500 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| March Altus Capital Management LP | 82,723 | $2,685,000 | 20.75% |
| HWG Holdings LP | 289,380 | $9,393,000 | 8.72% |
| Baker Brothers Advisors | 24,516,738 | $795,813,000 | 8.34% |
| HARVEY CAPITAL MANAGEMENT INC | 352,200 | $11,432,000 | 5.73% |
| Belmont Global Advisors, Inc. | 150,000 | $4,869,000 | 4.67% |
| Palo Alto Investors LP | 1,437,730 | $46,669,000 | 3.52% |
| Avoro Capital Advisors LLC | 329,500 | $10,696,000 | 2.38% |
| GARRISON BRADFORD & ASSOCIATES INC | 70,100 | $2,275,000 | 2.23% |
| WEATHERBIE CAPITAL, LLC | 401,642 | $13,037,000 | 1.85% |
| ACUTA CAPITAL PARTNERS, LLC | 85,999 | $2,792,000 | 1.34% |